Algorae Pharmaceuticals Limited

Algorae Pharmaceuticals Limitedverified

LVCLF

Price:

$0.0049

Market Cap:

$24.53M

Algorae Pharmaceuticals Limited, a pharmaceutical development company, engages in the research and development of living cells technologies primarily in New Zealand. The company's product pipeline includes AI-116, a novel combination drug candidate, which includes cannabidiol and an off-patent pharmaceutical ingredient for the of treatment for dementia, including Alzheimer's disease; NTCELL, an alginate coated capsule to target the treatment of Parkinson's disease; and AI-168, a novel combination drug candidate made up of a cannabinoid and an off-patent pharmaceutical ingredient to treat cardiovascular disease, including hypertension. It is also developing AlgaraeOS in partnership with the U...[Read more]

Industry

Biotechnology

IPO Date

2010-06-01

Stock Exchange

OTC

Ticker

LVCLF

The Enterprise Value as of December 2025 (TTM) for Algorae Pharmaceuticals Limited (LVCLF) is 21.43M

According to Algorae Pharmaceuticals Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 21.43M. This represents a change of 14.10% compared to the average of 18.78M of the last 4 quarters.

Algorae Pharmaceuticals Limited (LVCLF) Historical Enterprise Value (quarterly & annually)

How has LVCLF Enterprise Value performed in the past?

The mean historical Enterprise Value of Algorae Pharmaceuticals Limited over the last ten years is 17.12M. The current 21.43M Enterprise Value has changed 12.42% with respect to the historical average. Over the past ten years (40 quarters), LVCLF's Enterprise Value was at its highest in in the June 2010 quarter at 57.47M. The Enterprise Value was at its lowest in in the December 2021 quarter at -656740.69.

Quarterly (TTM)
Annual

Average

17.12M

Median

12.86M

Minimum

2.85M

Maximum

55.36M

Algorae Pharmaceuticals Limited (LVCLF) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Algorae Pharmaceuticals Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 463.88%

Maximum Annual Enterprise Value = 55.36M

Minimum Annual Increase = -85.05%

Minimum Annual Enterprise Value = 2.85M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202422.70M41.07%
202316.09M463.88%
20222.85M-49.90%
20215.70M25.05%
20204.56M-52.66%
20199.62M16.32%
20188.27M-85.05%
201755.36M85.75%
201629.80M84.07%
201516.19M9.86%

Algorae Pharmaceuticals Limited (LVCLF) Average Enterprise Value

How has LVCLF Enterprise Value performed in the past?

The current Enterprise Value of Algorae Pharmaceuticals Limited (LVCLF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

13.88M

5-year avg

10.38M

10-year avg

17.12M

Algorae Pharmaceuticals Limited (LVCLF) Enterprise Value vs. Peers

How is LVCLF’s Enterprise Value compared to its peers?

Algorae Pharmaceuticals Limited’s Enterprise Value is greater than HOOKIPA Pharma Inc. (-28576470.00), greater than Oxford BioDynamics Plc (6.42M), greater than Devonian Health Group Inc. (5.00M), less than EOM Pharmaceuticals Holdings, Inc. (22.39M), greater than Nymox Pharmaceutical Corporation (5.60M), greater than Hemostemix Inc. (20.00M), greater than Sirona Biochem Corp. (9.38M), greater than LianBio (-40025352.00), less than Valeo Pharma Inc. (57.68M), greater than Propanc Biopharma, Inc. (10.20M),

Build a custom stock screener for Algorae Pharmaceuticals Limited (LVCLF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Algorae Pharmaceuticals Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Algorae Pharmaceuticals Limited (LVCLF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Algorae Pharmaceuticals Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Algorae Pharmaceuticals Limited's Enterprise Value?

What is the highest Enterprise Value for Algorae Pharmaceuticals Limited (LVCLF)?

What is the 3-year average Enterprise Value for Algorae Pharmaceuticals Limited (LVCLF)?

What is the 5-year average Enterprise Value for Algorae Pharmaceuticals Limited (LVCLF)?

How does the current Enterprise Value for Algorae Pharmaceuticals Limited (LVCLF) compare to its historical average?